|
What are the problems for transplant recipients with CMV and EBV infection? How should you best deal with them?
�
Transplant patients, especially those who have had a lung and/or heart transplantation, often suffer from cytomegalovirus (CMV) infection. CMV can negatively impact the clinical outcome after transplantation, ultimately harming the chances of survival of both the graft and the host.
�
Epstein-Barr virus (EBV) is another herpesvirus that frequently triggers problems, causing post-transplant lymphoproliferative disease (PTLD), a major complication in transplant recipients. Management of PTLD is problematic due to difficulties with its diagnosis, prevention and treatment.
�
In this webinar, expert panellists Paolo Solidoro and Andrea Zuckermann will discuss the common sequelae of CMV and EBV infections after thoracic transplantation and center-specific clinical experiences when managing these infections. Christine Falk will act as the moderator for the webinar.
�
Join us to learn more about the burden of CMV and EBV infection for transplant patients and how best to tackle it.
�
|
